State of Wisconsin Investment Board’s Alder Biopharmaceuticals ALDR Stock Holding History

State of Wisconsin Investment Board’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-109,400	Closed	-$2.06M	–	1659
2019 Q3	$2.06M	Sell	109,400 -45,936	-30%	-$525K	0.01%	1011
2019 Q2	$1.83M	Buy	155,336 +72,036	+86%	+$872K	0.01%	1032
2019 Q1	$1.14M	Buy	83,300 +23,900	+40%	+$310K	﹤0.01%	1128
2018 Q4	$609K	Sell	59,400 -4,500	-7%	-$57.6K	﹤0.01%	1266
2018 Q3	$1.06M	Hold	63,900	–	–	﹤0.01%	1196
2018 Q2	$1.01M	Hold	63,900	–	–	﹤0.01%	1163
2018 Q1	$812K	Buy	63,900 +28,900	+83%	+$418K	﹤0.01%	1187
2017 Q4	$401K	Hold	35,000	–	–	﹤0.01%	1320
2017 Q3	$429K	Hold	35,000	–	–	﹤0.01%	1326
2017 Q2	$401K	Buy	+35,000	New	+$647K	﹤0.01%	1332
2016 Q4	–	Sell	-152,000	Closed	-$4.98M	–	1341
2016 Q3	$4.98M	Sell	152,000 -73,000	-32%	-$2.22M	0.02%	766
2016 Q2	$5.62M	Buy	+225,000	New	+$6.09M	0.02%	704

State of Wisconsin Investment Board's ALDR Position: Q4 2019 in Review

State of Wisconsin Investment Board sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 109,400 shares — an estimated $2.06M sold.

State of Wisconsin Investment Board first reported a position in ALDR in Q2 2016 and held it in 12 quarters. The position peaked at $5.62M in Q2 2016. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

State of Wisconsin Investment Board reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
State of Wisconsin Investment Board sold 109,400 Alder Biopharmaceuticals shares in Q4 2019, an estimated $2.06M.
State of Wisconsin Investment Board first reported a position in Alder Biopharmaceuticals in Q2 2016 and held it in 12 quarters.
State of Wisconsin Investment Board's Alder Biopharmaceuticals position peaked at $5.62M in Q2 2016.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2019, filed 14 Feb 2020.